Journal Menu
► ▼ Journal Menu-
- Viruses Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
1 December 2025
World AIDS Day, 1 December 2025
1 December is World AIDS Day, the day is an opportunity for public and private partners to spread awareness about the status of the pandemic and encourage progress in HIV/AIDS prevention, treatment, and care around the world. It has become one of the most widely recognized international health days.
In recognition of this day, we recommend the following related articles, Special Issues, and journals spanning multidisciplinary fields, including clinical medicine and biology. We believe that sharing such research can raise the public’s awareness and understanding of AIDS. The aim is to strengthen scientific cooperation in response to increased awareness about HIV/AIDS and to demonstrate international solidarity in the face of the pandemic.

| Biology & Life Science | Medicine & Pharmacology | Social Science, Art and Humanities |
|
||

“Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview”
by Alex C. Boomgarden and Chitra Upadhyay
Vaccines 2025, 13(2), 148; https://doi.org/10.3390/vaccines13020148
“Drug-Drug Interactions Between HIV Antivirals and Concomitant Drugs in HIV Patients: What We Know and What We Need to Know”
by Emanuela De Bellis, Danilo Donnarumma, Adele Zarrella, Salvatore Maria Mazzeo, Annarita Pagano, Valentina Manzo, Ines Mazza, Francesco Sabbatino, Graziamaria Corbi, Pasquale Pagliano et al.
Pharmaceutics 2025, 17(1), 31; https://doi.org/10.3390/pharmaceutics17010031
“High Prevalence of High-Risk HPV Among People with and Without HIV: Insights into Risk Factors for Tailored Screening Approaches”
by Elena Bruzzesi, Federica Gandini, Sara Diotallevi, Riccardo Lolatto, Massimo Cernuschi, Caterina Candela, Angelo Roberto Raccagni, Flavia Passini, Andrea Marco Tamburini, Roberto Burioni et al.
Microorganisms 2024, 12(12), 2571; https://doi.org/10.3390/microorganisms12122571
“Association Between Left Ventricular Diastolic Dysfunction, Systemic Inflammation, and Gastrointestinal Symptoms in HIV-Positive Patients on Antiretroviral Therapy”
by Madalina-Ianca Suba, Bogdan Hogea, Ahmed Abu-Awwad, Voichita Elena Lazureanu, Ovidiu Rosca, Daniela Gurgus, Sorina Maria Denisa Laitin and Alina Abu-Awwad
Diseases 2024, 12(12), 313; https://doi.org/10.3390/diseases12120313
“NSC95397 Is a Novel HIV-1 Latency-Reversing Agent”
by Randilea Nichols Doyle, Vivian Yang, Yetunde I. Kayode, Robert Damoiseaux, Harry E. Taylor and Oliver I. Fregoso
Viruses 2024, 16(11), 1783; https://doi.org/10.3390/v16111783
“HIV Self-Testing: A Discussion on the Benefits, Limitations, and Implications for Public Health with a Focus on Poland”
by Aleksandra Kozieł, Igor Domański, Aleksandra Szymczak, Tomasz Dudzik, Brygida Knysz and Bartosz Szetela
Diagnostics 2024, 14(22), 2475; https://doi.org/10.3390/diagnostics14222475
“Tumor Initiation and Progression in People Living on Antiretroviral Therapies”
by Seun E. Olufemi, Daniel A. Adediran, Temitope Sobodu, Isaac O. Adejumo, Olumide F. Ajani and Elijah K. Oladipo
Biologics 2024, 4(4), 390-406; https://doi.org/10.3390/biologics4040024
“J3ExoA: A Novel Anti-HIV Immunotoxin Fusion of Anti-Gp120 J3VHH and PE38 Fragment of Pseudomonas Exotoxin A”
by Seth H. Pincus, Kun Luo, Tami Peters, James T. Gordy, Frances M. Cole, Grant Klug, Kelli Ober, Tamera K. Marcotte and Richard B. Markham
Pharmaceuticals 2025, 18(9), 1305; https://doi.org/10.3390/ph18091305
“A Memo on Factors Associated with Perception of Stigma Attached to PrEP: Evidence from the Keeping It LITE Study”
by Shahin Davoudpour, Gregory L. Phillips II, Pedro A. Serrano, Audrey L. French and Sybil G. Hosek
Sexes 2024, 5(3), 300-316; https://doi.org/10.3390/sexes5030023
“Effects of E-Cigarettes on the Lung and Systemic Metabolome in People with HIV”
by Aline Zaparte, Courtney J. Christopher, Connie Arnold, Lauren Richey, Adairre Castille, Kyle Mistretta, Christopher M. Taylor, Huiyi Lin, Steve Nelson, John P. Kirwan, John W. Apolzan, Shawn R. Campagna and David A. Welsh
Metabolites 2024, 14(8), 434; https://doi.org/10.3390/metabo14080434
“Bone Tissue Changes in Individuals Living with HIV/AIDS: The Importance of a Hierarchical Approach in Investigating Bone Fragility”
by Jelena Jadzic, Gordana Dragovic, Relja Lukic, Bozana Obradovic and Marija Djuric
J. Pers. Med. 2024, 14(8), 791; https://doi.org/10.3390/jpm14080791
“Advanced Therapies for Human Immunodeficiency Virus”
by Daniel Josef Lindegger
Med. Sci. 2024, 12(3), 33; https://doi.org/10.3390/medsci12030033
“Antiretroviral Therapy Switch in HIV-Infected Adults from a Regional HIV/AIDS Center in NE Romania”
by Isabela Ioana Loghin, Șerban Alin Rusu, Andrei Vâţă, Mihaela Cobaschi, Ion Cecan, Carmen Manciuc and Carmen Mihaela Dorobăţ
Medicina 2024, 60(6), 854; https://doi.org/10.3390/medicina60060854
“Alterations in the Gut Microbiome Composition of People Living with HIV in the Asia–Pacific Region: A Systematic Review”
by Paul Benedic U. Salvador, Patrick Josemaria d. R. Altavas, Mark Angelo S. del Rosario, Eric David B. Ornos and Leslie Michelle M. Dalmacio
Clin. Pract. 2024, 14(3), 846-861; https://doi.org/10.3390/clinpract14030066
“Systematic Review: HIV, Aging, and Housing—A North American Perspective, 2012–2023”
by Arthur S. Chaminuka, Gayle Prybutok, Victor R. Prybutok and William D. Senn
Healthcare 2024, 12(10), 992; https://doi.org/10.3390/healthcare12100992
“The Role of MicroRNAs in HIV Infection”
by Nicolas Morando, Mara Cecilia Rosenzvit, Maria A. Pando and Jens Allmer
Genes 2024, 15(5), 574; https://doi.org/10.3390/genes15050574

|
“HIV-TB Co-Infection and Pediatric Pathogen Dynamics” |
“HIV Expression in Diverse Cell Types: Mechanisms, Regulation, and Pathogenesis” |
![]() |
![]() |
|
“Research on HIV/AIDS Vaccine” |
“Gene and Cell Therapy: New Findings from Medical Research and Treatment” |
![]() |
![]() |
|
“Emerging Knowledge on Human Immunodeficiency Virus” |
“Nutrition Intervention in HIV Patients” |
![]() |
![]() |
28 November 2025
Viruses | Selected Papers on CRISPR Antiviral Strategies
1. “CRISPR/Cas9-Mediated Resistance to Wheat Dwarf Virus in Hexaploid Wheat (Triticum aestivum L.)”
by Xiaoyu Yuan, Keya Xu, Fang Yan, Zhiyuan Liu, Carl Spetz, Huanbin Zhou, Xiaojie Wang, Huaibing Jin, Xifeng Wang and Yan Liu
Viruses 2024, 16(9), 1382; https://doi.org/10.3390/v16091382
Available online: https://www.mdpi.com/1999-4915/16/9/1382

2. “CRISPR Screen Reveals PACT as a Pro-Viral Factor for Dengue Viral Replication”
by Shwetha Shivaprasad, Wenjie Qiao, Kuo-Feng Weng, Pavithra Umashankar, Jan E. Carette and Peter Sarnow
Viruses 2024, 16(5), 725; https://doi.org/10.3390/v16050725
Available online: https://www.mdpi.com/1999-4915/16/5/725

3. “Applications of CRISPR/Cas as a Toolbox for Hepatitis B Virus Detection and Therapeutics”
by Anuj Kumar, Emmanuel Combe, Léa Mougené, Fabien Zoulim and Barbara Testoni
Viruses 2024, 16(10), 1565; https://doi.org/10.3390/v16101565
Available online: https://www.mdpi.com/1999-4915/16/10/1565 
4. “Resistance of the CRISPR-Cas13a Gene-Editing System to Potato Spindle Tuber Viroid Infection in Tomato and Nicotiana benthamiana”
by Ying Wei Khoo, Qingsong Wang, Shangwu Liu, Binhui Zhan, Tengfei Xu, Wenxia Lv, Guangjing Liu, Shifang Li and Zhixiang Zhang
Viruses 2024, 16(9), 1401; https://doi.org/10.3390/v16091401
Available online: https://www.mdpi.com/1999-4915/16/9/1401

5. “Modulation of Equid Herpesvirus-1 Replication Dynamics In Vitro Using CRISPR/Cas9-Assisted Genome Editing”
by Rabab T. Hassanien, Côme J. Thieulent, Mariano Carossino, Ganwu Li and Udeni B. R. Balasuriya
Viruses 2024, 16(3), 409; https://doi.org/10.3390/v16030409
Available online: https://www.mdpi.com/1999-4915/16/3/409

6. “A CRISPR-Cas13b System Degrades SARS-CoV and SARS-CoV-2 RNA In Vitro”
by Klara Andersson, Ani Azatyan, Martin Ekenberg, Gözde Güçlüler, Laura Sardon Puig, Marjo Puumalainen, Theodor Pramer, Vanessa M. Monteil and Ali Mirazimi
Viruses 2024, 16(10), 1539; https://doi.org/10.3390/v16101539
Available online: https://www.mdpi.com/1999-4915/16/10/1539

7. “CRISPR/Cas9-Driven Engineering of AcMNPV Using Dual gRNA for Optimized Recombinant Protein Production”
by Rocco Valente, Joaquín Poodts, Joaquín Manuel Birenbaum, María Sol Rodriguez, Ignacio Smith, Jorge Alejandro Simonin, Franco Uriel Cuccovia Warlet, Aldana Trabucchi, Salvador Herrero, María Victoria Miranda et al.
Viruses 2025, 17(8), 1041; https://doi.org/10.3390/v17081041
Available online: https://www.mdpi.com/1999-4915/17/8/1041

8. “The First CRISPR-Based Therapeutic (SL_1.52) for African Swine Fever Is Effective in Swine”
by Naveen Verma, Alison O’Mahony, Roky Mohammad, Dylan Keiser, Craig W. Mosman, Deric Holden, Kristin Starr, Jared Bauer, Bradley Bauer, Roypim Suntisukwattana, Waranya Atthaapa, Angkana Tantituvanont, Dachrit Nilubol and Douglas P. Gladue
Viruses 2025, 17(11), 1504; https://doi.org/10.3390/v17111504
Available online: https://www.mdpi.com/1999-4915/17/11/1504

28 November 2025
Viruses | Selected Papers on Influenza A Virus
1. “The Influenza A Virus Replication Cycle: A Comprehensive Review”
by Toby Carter and Munir Iqbal
Viruses 2024, 16(2), 316; https://doi.org/10.3390/v16020316
Available online: https://www.mdpi.com/1999-4915/16/2/316
2. “Emerging Threats of Highly Pathogenic Avian Influenza A (H5N1) in US Dairy Cattle: Understanding Cross-Species Transmission Dynamics in Mammalian Hosts”
by Chithra C. Sreenivasan, Feng Li and Dan Wang
Viruses 2024, 16(11), 1703; https://doi.org/10.3390/v16111703
Available online: https://www.mdpi.com/1999-4915/16/11/1703
3. “Exploring Potential Intermediates in the Cross-Species Transmission of Influenza A Virus to Humans”
by Chung-Young Lee
Viruses 2024, 16(7), 1129; https://doi.org/10.3390/v16071129
Available online: https://www.mdpi.com/1999-4915/16/7/1129
4. “Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19”
by Jordan J. Clark, Rebekah Penrice-Randal, Parul Sharma, Xiaofeng Dong, Shaun H. Pennington, Amy E. Marriott, Stefano Colombo, Andrew Davidson, Maia Kavanagh Williamson, David A. Matthews et al.
Viruses 2024, 16(6), 863; https://doi.org/10.3390/v16060863
Available online: https://www.mdpi.com/1999-4915/16/6/863
5. “Natural Infection with Highly Pathogenic Avian Influenza A/H5N1 Virus in Pet Ferrets”
by Anna Golke, Dawid Jańczak, Olga Szaluś-Jordanow, Tomasz Dzieciątkowski, Rafał Sapierzyński, Agata Moroz-Fik, Marcin Mickiewicz and Tadeusz Frymus
Viruses 2024, 16(6), 931; https://doi.org/10.3390/v16060931
Available online: https://www.mdpi.com/1999-4915/16/6/931
6. “Detection and Monitoring of Highly Pathogenic Influenza A Virus 2.3.4.4b Outbreak in Dairy Cattle in the United States”
by Luis G. Giménez-Lirola, Brooklyn Cauwels, Juan Carlos Mora-Díaz, Ronaldo Magtoto, Jesús Hernández, Maritza Cordero-Ortiz, Rahul K. Nelli, Patrick J. Gorden, Drew R. Magstadt and David H. Baum
Viruses 2024, 16(9), 1376; https://doi.org/10.3390/v16091376
Available online: https://www.mdpi.com/1999-4915/16/9/1376
7. “Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice”
by Jackelyn Murray, David E. Martin, Sarah Hosking, Nichole Orr-Burks, Robert J. Hogan and Ralph A. Tripp
Viruses 2024, 16(1), 152; https://doi.org/10.3390/v16010152
Available online: https://www.mdpi.com/1999-4915/16/1/152
8. “Novel Anti-Viral Properties of the Herbal Extract of Davallia mariesii against Influenza A Virus”
by Yu-Li Chen, Pei-Yu Chao, Chung-Fan Hsieh, Pei-Wen Hsieh and Jim-Tong Horng
Viruses 2024, 16(4), 523; https://doi.org/10.3390/v16040523
Available online: https://www.mdpi.com/1999-4915/16/4/523
26 November 2025
Viruses | Highly Cited Papers Published in 2024 in the “Viral Immunology, Vaccines, and Antivirals” Section
1. “Human Papillomavirus and Associated Cancers: A Review”
by JaNiese E. Jensen, Greta L. Becker, J. Brooks Jackson and Mary B. Rysavy
Viruses 2024, 16(5), 680; https://doi.org/10.3390/v16050680
Available online: https://www.mdpi.com/1999-4915/16/5/680

2. “Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection”
by Wenli Mu, Vaibhavi Patankar, Scott Kitchen and Anjie Zhen
Viruses 2024, 16(2), 219; https://doi.org/10.3390/v16020219
Available online: https://www.mdpi.com/1999-4915/16/2/219

3. “Profiling the Interaction between Human Serum Albumin and Clinically Relevant HIV Reverse Transcriptase Inhibitors”
by Andreia Costa-Tuna, Otávio A. Chaves, Zaida L. Almeida, Rita S. Cunha, João Pina and Carlos Serpa
Viruses 2024, 16(4), 491; https://doi.org/10.3390/v16040491
Available online: https://www.mdpi.com/1999-4915/16/4/491

4. “Recent Advances on Targeting Proteases for Antiviral Development”
by Pedro Henrique Oliveira Borges, Sabrina Baptista Ferreira and Floriano Paes Silva
Viruses 2024, 16(3), 366; https://doi.org/10.3390/v16030366
Available online: https://www.mdpi.com/1999-4915/16/3/366

5. “Macrophages: Key Cellular Players in HIV Infection and Pathogenesis”
by Marie Woottum, Sen Yan, Sophie Sayettat, Séverine Grinberg, Dominique Cathelin, Nassima Bekaddour, Jean-Philippe Herbeuval and Serge Benichou
Viruses 2024, 16(2), 288; https://doi.org/10.3390/v16020288
Available online: https://www.mdpi.com/1999-4915/16/2/288

6. “Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 Outcomes”
by Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Ihor Vorobets, Iryna Halabitska and Oleksandr Kamyshnyi
Viruses 2024, 16(6), 985; https://doi.org/10.3390/v16060985
Available online: https://www.mdpi.com/1999-4915/16/6/985

7. “Probenecid Inhibits Human Metapneumovirus (HMPV) Replication In Vitro and in BALB/c Mice”
by Harrison C. Bergeron, Jackelyn Crabtree, Tamas Nagy, David E. Martin and Ralph A. Tripp
Viruses 2024, 16(7), 1087; https://doi.org/10.3390/v16071087
Available online: https://www.mdpi.com/1999-4915/16/7/1087

8. “mRNA Vaccine Nanoplatforms and Innate Immunity”
by Lai Wei, Chunhong Dong, Wandi Zhu and Bao-Zhong Wang
Viruses 2024, 16(1), 120; https://doi.org/10.3390/v16010120
Available online: https://www.mdpi.com/1999-4915/16/1/120

9. “On-Site and Visual Detection of the H5 Subtype Avian Influenza Virus Based on RT-RPA and CRISPR/Cas12a”
by Xu Zhou, Siwen Wang, Yue Ma, Yongping Jiang, Yanbing Li, Jianzhong Shi, Guohua Deng, Guobin Tian, Huihui Kong and Xiurong Wang
Viruses 2024, 16(5), 753; https://doi.org/10.3390/v16050753
Available online: https://www.mdpi.com/1999-4915/16/5/753

10. “The Mathematical Modeling of the Host–Virus Interaction in Dengue Virus Infection: A Quantitative Study”
by Zhaobin Xu, Hongmei Zhang, Dongying Yang, Dongqing Wei, Jacques Demongeot and Qiangcheng Zeng
Viruses 2024, 16(2), 216; https://doi.org/10.3390/v16020216
Available online: https://www.mdpi.com/1999-4915/16/2/216

26 November 2025
Viruses | Highly Cited Papers Published in 2024 in the “General Virology” Section
1. “Human Oncogenic Viruses: Characteristics and Prevention Strategies—Lessons Learned from Human Papillomaviruses”
by Luisa Galati, Maria Vincenza Chiantore, Mariarosaria Marinaro and Paola Di Bonito
Viruses 2024, 16(3), 416; https://doi.org/10.3390/v16030416
Available online: https://www.mdpi.com/1999-4915/16/3/416

2. “VOGDB—Database of Virus Orthologous Groups”
by Lovro Trgovec-Greif, Hans-Jörg Hellinger, Jean Mainguy, Alexander Pfundner, Dmitrij Frishman, Michael Kiening, Nicole Suzanne Webster, Patrick William Laffy, Michael Feichtinger and Thomas Rattei
Viruses 2024, 16(8), 1191; https://doi.org/10.3390/v16081191
Available online: https://www.mdpi.com/1999-4915/16/8/1191

3. “The Contribution of Microglia and Brain-Infiltrating Macrophages to the Pathogenesis of Neuroinflammatory and Neurodegenerative Diseases during TMEV Infection of the Central Nervous System”
by Ana Beatriz DePaula-Silva
Viruses 2024, 16(1), 119; https://doi.org/10.3390/v16010119
Available online: https://www.mdpi.com/1999-4915/16/1/119

4. “Epigenetic Control of Innate Immunity: Consequences of Acute Respiratory Virus Infection”
by Rivka Bella Lefkowitz, Clare M. Miller, Juan David Martinez-Caballero and Irene Ramos
Viruses 2024, 16(2), 197; https://doi.org/10.3390/v16020197
Available online: https://www.mdpi.com/1999-4915/16/2/197
5. “Protein Nanoparticles as Vaccine Platforms for Human and Zoonotic Viruses”
by Kush K. Pandey, Bikash R. Sahoo and Asit K. Pattnaik
Viruses 2024, 16(6), 936; https://doi.org/10.3390/v16060936
Available online: https://www.mdpi.com/1999-4915/16/6/936

6. “Functional Impacts of Epitranscriptomic m6A Modification on HIV-1 Infection”
by Stacia Phillips, Tarun Mishra, Siyu Huang and Li Wu
Viruses 2024, 16(1), 127; https://doi.org/10.3390/v16010127
Available online: https://www.mdpi.com/1999-4915/16/1/127

7. “Wastewater-Based Epidemiology for Viral Surveillance from an Endemic Perspective: Evidence and Challenges”
by Marco Verani, Alessandra Pagani, Ileana Federigi, Giulia Lauretani, Nebiyu Tariku Atomsa, Virginia Rossi, Luca Viviani and Annalaura Carducci
Viruses 2024, 16(3), 482; https://doi.org/10.3390/v16030482
Available online: https://www.mdpi.com/1999-4915/16/3/482

8. “Accumulation Dynamics of Defective Genomes during Experimental Evolution of Two Betacoronaviruses”
by Julia Hillung, María J. Olmo-Uceda, Juan C. Muñoz-Sánchez and Santiago F. Elena
Viruses 2024, 16(4), 644; https://doi.org/10.3390/v16040644
Available online: https://www.mdpi.com/1999-4915/16/4/644

9. “Chandipura Virus Forms Cytoplasmic Inclusion Bodies through Phase Separation and Proviral Association of Cellular Protein Kinase R and Stress Granule Protein TIA-1”
by Sharmistha Sarkar, Surajit Ganguly, Nirmal K. Ganguly, Debi P. Sarkar and Nishi Raj Sharma
Viruses 2024, 16(7), 1027; https://doi.org/10.3390/v16071027
Available online: https://www.mdpi.com/1999-4915/16/7/1027

10. “Community Structure, Drivers, and Potential Functions of Different Lifestyle Viruses in Chaohu Lake”
by Yu Zheng, Zihao Gao, Shuai Wu and Aidong Ruan
Viruses 2024, 16(4), 590; https://doi.org/10.3390/v16040590
Available online: https://www.mdpi.com/1999-4915/16/4/590

6 November 2025
MDPI Launches the Michele Parrinello Award for Pioneering Contributions in Computational Physical Science
MDPI is delighted to announce the establishment of the Michele Parrinello Award. Named in honor of Professor Michele Parrinello, the award celebrates his exceptional contributions and his profound impact on the field of computational physical science research.
The award will be presented biennially to distinguished scientists who have made outstanding achievements and contributions in the field of computational physical science—spanning physics, chemistry, and materials science.
About Professor Michele Parrinello
"Do not be afraid of new things. I see it many times when we discuss a new thing that young people are scared to go against the mainstream a little bit, thinking what is going to happen to me and so on. Be confident that what you do is meaningful, and do not be afraid, do not listen too much to what other people have to say.”
——Professor Michele Parrinello
![]() |
Born in Messina in 1945, he received his degree from the University of Bologna and is currently affiliated with the Italian Institute of Technology. Professor Parrinello is known for his many technical innovations in the field of atomistic simulations and for a wealth of interdisciplinary applications ranging from materials science to chemistry and biology. Together with Roberto Car, he introduced ab initio molecular dynamics, also known as the Car–Parrinello method, marking the beginning of a new era both in the area of electronic structure calculations and in molecular dynamics simulations. He is also known for the Parrinello–Rahman method, which allows crystalline phase transitions to be studied by molecular dynamics. More recently, he has introduced metadynamics for the study of rare events and the calculation of free energies. |
For his work, he has been awarded many prizes and honorary degrees. He is a member of numerous academies and learned societies, including the German Berlin-Brandenburgische Akademie der Wissenschaften, the British Royal Society, and the Italian Accademia Nazionale dei Lincei, which is the major academy in his home country of Italy.
Award Committee
![]() |
The award committee will be chaired by Professor Xin-Gao Gong, a computational condensed matter physicist, academician of the Chinese Academy of Sciences, and professor at the Department of Physics, Fudan University. Professor Xin-Gao Gong will lead a panel of several senior experts in the field to oversee the evaluation and selection process. The Institute for Computational Physical Sciences at Fudan University (Shanghai, China), led by Professor Xin-Gao Gong, will serve as the supporting institute for the award. |
"We hope the Michele Parrinello Award will recognize scientists who have made significant contributions to the field of computational condensed matter physics and at the same time set a benchmark for the younger generation, providing clear direction for their pursuit—this is precisely the original intention behind establishing the award."
——Professor Xin-Gao Gong
The first edition of the award was officially launched on 1 November 2025. Nominations will be accepted before the end of March 2026. For further details, please visit mparrinelloaward.org.
About the MDPI Sustainability Foundation and MDPI Awards 
The Michele Parrinello Award is part of the MDPI Sustainability Foundation, which is dedicated to advancing sustainable development through scientific progress and global collaboration. The foundation also oversees the World Sustainability Award, the Emerging Sustainability Leader Award, and the Tu Youyou Award. The establishment of the Michele Parrinello Award will further enrich the existing award portfolio, providing continued and diversified financial support to outstanding professionals across various fields.
In addition to these foundation-level awards, MDPI journals also recognize outstanding contributions through a range of honors, including Best Paper Awards, Outstanding Reviewer Awards, Young Investigator Awards, Travel Awards, Best PhD Thesis Awards, Editor of Distinction Awards, and others. These initiatives aim to recognize excellence across disciplines and career stages, contributing to the long-term vitality and sustainability of scientific research.
Find more information on awards here.
5 November 2025
Viruses | Selected Papers on Chikungunya Virus (CHIKV)
1. “Effect of Viral Strain and Host Age on Clinical Disease and Viral Replication in Immunocompetent Mouse Models of Chikungunya Encephalomyelitis”
by Elizabeth J. Anderson, Audrey C. Knight, Mark T. Heise and Victoria K. Baxter
Viruses 2023, 15(5), 1057; https://doi.org/10.3390/v15051057
Available online: https://www.mdpi.com/1999-4915/15/5/1057

2. “Determinants of Chikungunya and O’nyong-Nyong Virus Specificity for Infection of Aedes and Anopheles Mosquito Vectors”
by Solène Cottis, Adrien A. Blisnick, Anna-Bella Failloux and Kenneth D. Vernick
Viruses 2023, 15(3), 589; https://doi.org/10.3390/v15030589
Available online: https://www.mdpi.com/1999-4915/15/3/589

3. “Serological and Molecular Epidemiology of Chikungunya Virus Infection in Vietnam, 2017–2019”
by Thanh Vu Nguyen, Mya Myat Ngwe Tun, Minh Thang Cao, Huy Manh Dao, Chan Quang Luong, Thi Kim Loan Huynh, Thi Thanh Thuong Nguyen, Thi Nhu Dao Hoang, Kouichi Morita, Thi Quynh Mai Le et al.
Viruses 2023, 15(10), 2065; https://doi.org/10.3390/v15102065
Available online: https://www.mdpi.com/1999-4915/15/10/2065

4. “Ecological Niche Modeling of Aedes and Culex Mosquitoes: A Risk Map for Chikungunya and West Nile Viruses in Zambia”
by Rachel Milomba Velu, Geoffrey Kwenda, Samuel Bosomprah, Moses Ngongo Chisola, Michelo Simunyandi, Caroline Cleopatra Chisenga, Flavien Nsoni Bumbangi, Nicholus Chintu Sande, Limonty Simubali, Monicah Mirai Mburu et al.
Viruses 2023, 15(9), 1900; https://doi.org/10.3390/v15091900
Available online: https://www.mdpi.com/1999-4915/15/9/1900

5. “Detection of Chikungunya Virus RNA in Oral Fluid and Urine: An Alternative Approach to Diagnosis?”
by Leile Camila Jacob-Nascimento, Moyra M. Portilho, Rosângela O. Anjos, Patrícia S. S. Moreira, Christine Stauber, Scott C. Weaver, Uriel Kitron, Mitermayer G. Reis and Guilherme S. Ribeiro
Viruses 2024, 16(2), 235; https://doi.org/10.3390/v16020235
Available online: https://www.mdpi.com/1999-4915/16/2/235

6. “Cross-Neutralizing Anti-Chikungunya and Anti-Dengue 2 IgG Antibodies from Patients and BALB/c Mice against Dengue and Chikungunya Viruses”
by Araceli Posadas-Mondragón, José Angel Santiago-Cruz, Angélica Pérez-Juárez, Norma Estela Herrera-González, Sara M. Sosa-Delgado, Claudia Elena Wong-Arámbula, Abril Paulina Rodríguez-Maldonado, Mauricio Vázquez-Pichardo, Daniel Duran-Ayala and José Leopoldo Aguilar-Faisal
Viruses 2024, 16(7), 1098; https://doi.org/10.3390/v16071098
Available online: https://www.mdpi.com/1999-4915/16/7/1098

7. “The High Capacity of Brazilian Aedes aegypti Populations to Transmit a Locally Circulating Lineage of Chikungunya Virus”
by Amanda de Freitas, Fernanda Rezende, Silvana de Mendonça, Lívia Baldon, Emanuel Silva, Flávia Ferreira, João Almeida, Siad Amadou, Bruno Marçal, Sara Comini et al.
Viruses 2024, 16(4), 575; https://doi.org/10.3390/v16040575
Available online: https://www.mdpi.com/1999-4915/16/4/575

8. “Elucidation of the Epitranscriptomic RNA Modification Landscape of Chikungunya Virus”
by Belinda Baquero-Pérez, Enrico Bortoletto, Umberto Rosani, Anna Delgado-Tejedor, Rebeca Medina, Eva Maria Novoa, Paola Venier and Juana Díez
Viruses 2024, 16(6), 945; https://doi.org/10.3390/v16060945
Available online: https://www.mdpi.com/1999-4915/16/6/945

9. “The Chikungunya Virus nsP3 Macro Domain Inhibits Activation of the NF-κB Pathway”
by Grace C. Roberts, Nicola J. Stonehouse and Mark Harris
Viruses 2025, 17(2), 191; https://doi.org/10.3390/v17020191
Available online: https://www.mdpi.com/1999-4915/17/2/191

10. “Acute Chikungunya Virus Infection Triggers a Diverse Range of T Helper Lymphocyte Profiles”
by Ramayana Morais de Medeiros Brito, Marília Farias de Melo, José Veríssimo Fernandes, Joanna Gardel Valverde, Paulo Marcos Matta Guedes, Josélio Maria Galvão de Araújo and Manuela Sales Lima Nascimento
Viruses 2024, 16(9), 1387; https://doi.org/10.3390/v16091387
Available online: https://www.mdpi.com/1999-4915/16/9/1387

4 November 2025
Viruses | Highly Cited Papers Published in 2024 in the “Human Virology and Viral Diseases” Section
1. “Mpox (Monkeypox) Virus and Its Co-Infection with HIV, Sexually Transmitted Infections, or Bacterial Superinfections: Double Whammy or a New Prime Culprit?”
by Benjamin M. Liu, Natella Y. Rakhmanina, Zhilong Yang and Michael I. Bukrinsky
Viruses 2024, 16(5), 784; https://doi.org/10.3390/v16050784
Available online: https://www.mdpi.com/1999-4915/16/5/784

2. “Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape”
by Eleftheria Kampouri, Guy Handley and Joshua A. Hill
Viruses 2024, 16(4), 498; https://doi.org/10.3390/v16040498
Available online: https://www.mdpi.com/1999-4915/16/4/498

3. “Hepatitis B Viral Protein HBx: Roles in Viral Replication and Hepatocarcinogenesis”
by Dong Li, Yassir Hamadalnil and Thomas Tu
Viruses 2024, 16(9), 1361; https://doi.org/10.3390/v16091361
Available online: https://www.mdpi.com/1999-4915/16/9/1361

4. “HIV–TB Coinfection: Current Therapeutic Approaches and Drug Interactions”
by Inesa Navasardyan, Rita Miwalian, Aelita Petrosyan, Stephanie Yeganyan and Vishwanath Venketaraman
Viruses 2024, 16(3), 321; https://doi.org/10.3390/v16030321
Available online: https://www.mdpi.com/1999-4915/16/3/321

5. “Models of Herpes Simplex Virus Latency”
by Paige N. Canova, Audra J. Charron and David A. Leib
Viruses 2024, 16(5), 747; https://doi.org/10.3390/v16050747
Available online: https://www.mdpi.com/1999-4915/16/5/747

6. “The Anti-SARS-CoV-2 IgG1 and IgG3 Antibody Isotypes with Limited Neutralizing Capacity against Omicron Elicited in a Latin Population a Switch toward IgG4 after Multiple Doses with the mRNA Pfizer–BioNTech Vaccine”
by Ana M. Espino, Albersy Armina-Rodriguez, Laura Alvarez, Carlimar Ocasio-Malavé, Riseilly Ramos-Nieves, Esteban I. Rodriguez Martinó, Paola López-Marte, Esther A. Torres and Carlos A. Sariol
Viruses 2024, 16(2), 187; https://doi.org/10.3390/v16020187
Available online: https://www.mdpi.com/1999-4915/16/2/187

7. “Unveiling of the Co-Infection of Peste des Petits Ruminants Virus and Caprine Enterovirus in Goat Herds with Severe Diarrhea in China”
by Qun Zhang, Xuebo Zheng, Fan Zhang, Xuyuan Cui, Naitian Yan, Junying Hu, Yidi Guo and Xinping Wang
Viruses 2024, 16(6), 986; https://doi.org/10.3390/v16060986
Available online: https://www.mdpi.com/1999-4915/16/6/986

8. “Full Genome Characterization of the First Oropouche Virus Isolate Imported in Europe from Cuba”
by Michela Deiana, Simone Malagò, Antonio Mori, Silvia Accordini, Andrea Matucci, Rebeca Passarelli Mantovani, Natasha Gianesini, Ralph Huits, Chiara Piubelli, Federico Giovanni Gobbi et al.
Viruses 2024, 16(10), 1586; https://doi.org/10.3390/v16101586
Available online: https://www.mdpi.com/1999-4915/16/10/1586

9. “Presence and Significance of Multiple Respiratory Viral Infections in Children Admitted to a Tertiary Pediatric Hospital in Italy”
by Velia Chiara Di Maio, Rossana Scutari, Lorena Forqué, Luna Colagrossi, Luana Coltella, Stefania Ranno, Giulia Linardos, Leonarda Gentile, Eugenia Galeno, Anna Chiara Vittucci et al.
Viruses 2024, 16(5), 750; https://doi.org/10.3390/v16050750
Available online: https://www.mdpi.com/1999-4915/16/5/750

10. “Mesenchymal Stem Cell-Derived Exosomes Attenuate Murine Cytomegalovirus-Infected Pneumonia via NF-κB/NLRP3 Signaling Pathway”
by Fei Chen, Zhida Chen, Hui-Ting Wu, Xin-Xiang Chen, Peiqi Zhan, Zheng-Yi Wei, Zizhang Ouyang, Xueyan Jiang, Ao Shen, Min-Hua Luo, Qifa Liu, Yue-Peng Zhou and Aiping Qin
Viruses 2024, 16(4), 619; https://doi.org/10.3390/v16040619
Available online: https://www.mdpi.com/1999-4915/16/4/619

4 November 2025
MDPI INSIGHTS: The CEO's Letter #28 - WSF11, Nobel Laureates, Proofig AI, Romania Summit, STM and FBF
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts

Highlights from the 11th World Sustainability Forum in Barcelona
I’m pleased to share some highlights from the 11th World Sustainability Forum (WSF 11), held in Barcelona on 2–3 October 2025 under the theme Sustainable and Resilient Cities.
Why WSF matters
The WSF series is a flagship initiative for MDPI and is supported by the MDPI Sustainability Foundation. It serves as a transdisciplinary platform for researchers, policymakers, and stakeholders to engage on sustainability challenges. WSF is now held annually as part of our commitment to maintain momentum in the sustainability discourse.
|
|
|
|
This year’s Barcelona edition focused on urban resilience, landscape design, and social community impact in the sustainability space. Over 48 hours of sessions, we brought together leading minds across disciplines to translate vision into practice. With participants from 53 countries across all continents, WSF 11 was truly global in scope.

“WSF is now held annually as part of our commitment to maintain momentum in the sustainability discourse”
What made WSF 11 especially successful (from my vantage point) was the level of positive engagement with our participants. Chief editors, researchers, and attendees repeatedly told me how professionally executed the event was, highlighting the high energy, logistical smoothness and quality of MDPI’s event management. That kind of recognition from peers really builds our reputation as more than just a publisher, but as a convener of meaningful scientific dialogue.
Our conferences are a form of experiential marketing as they create memorable and immersive connections between a brand and attendees. These positive associations build promotion and brand loyalty, ultimately impacting the MDPI’s trust and reputation for the better.
WSF 11: By the numbers
Here’s a quick snapshot of WSF 11’s scale and reach:
- 181 registrations across global participants.
- 8 keynote speakers and 5 invited speakers.
- 144 abstracts accepted (over 355 submitted), resulting in 75 short talks and 69 posters.
- 53 countries were represented across all continents, making it a truly international event.
- First time that we ran parallel sessions for WSF (an ambitious program).
- A dedicated awards ceremony to honour outstanding sustainability research: World Sustainability Award (WSA) x 2 winners, and Emerging Sustainability Leader Award (ESLA) x 3 winners.
Interviews with our World Sustainability Award Winners
One of the most rewarding parts of WSF is recognizing researchers whose work advances sustainability in powerful ways. In our Blog series, Daniella Maritan-Thomson (Content Specialist, MDPI) interviewed the two winners of the World Sustainability Award, Professor Dr. Stuart Pimm and Dr. Abdelbagi M. Ismail, who offered insights to the human side of sustainability research, the people behind the data, and the stories behind the science.
|
|
Prof. Stuart Pimm, whose decades of conservation work make him a leader in biodiversity preservation, reflected on his WSF Award experience and research in this interview: [Interview: Prof Stuart Pimm] |
|
|
Dr. Abdelbagi M. Ismail, an expert in crop improvement and winner of the WSF Award, shares his journey and perspectives here: [Interview: Dr Abdelbagi M. Ismail] |
“Our conferences create memorable and immersive connections”
Emerging Sustainability Leader Award winners

Stefan Tochev (CEO, MDPI), Prof. Dr. Vhahangwele Masindi, Dr. Katya Rhodes, and Prof. Dr. Myriam Ertz (left to right).
We also recognized three recipients of the Emerging Sustainability Leader Award: Prof. Dr. Vhahangwele Masindi, Dr. Katya Rhodes, and Prof. Dr. Myriam Ertz, for their contributions as early-career researchers advancing sustainability through innovation, impact, and academic excellence across the field.
What this means for MDPI
- Building our global identity in events
WSF is a marquee MDPI event, not just a gathering, but a statement of how we wish to position ourselves in the global sustainability ecosystem. The positive feedback helps us build on our approach for future editions, so that we remain a reference point for quality, relevance, and engagement. - Expanding capacity across offices
The success of WSF 11 in Barcelona’s would not have happened without great teamwork from Basel, Barcelona, Romania, the UK, and the APAC Conference team. Thanks to everyone for their work to bring this ambitious event to life. - Supporting MDPI’s mission
At this event, I had the opportunity to present on MDPI's role in Open Access, sustainability publishing, and the intersection of science and policy. WSF is not only about the science; it’s also a platform for us to position MDPI as a thought leader and a collaborator in shaping the future of sustainable research.
I look forward to the WSF momentum as we work towards WSF 12 in Hong Kong, which is scheduled for August 2026.

MDPI Colleagues at the 11th World Sustainability Forum in Barcelona, Spain, 2–3 October 2025.
Impactful Research

Celebrating 2025 Nobel Laureates who have published with MDPI
October is always an inspiring month in science. It’s when the world turns its attention to the Nobel Prize announcements, recognizing discoveries that have changed how we understand the world.
Over the years, many distinguished researchers who have received the Nobel Prize have chosen to publish their work with MDPI. These are scientists whose breakthroughs have shaped entire fields of research, and who have entrusted our Open Access journals to share their findings with the world.
“The work we support can be world-class and world-changing”
Congratulations to the 2025 Laureates
Dozens of Nobel Laureates have published in our journals: as at 2024, more than 40 laureates had contributed over 115 articles across more than 35 MDPI journals. Congratulations to the three 2025 Nobel prize-winners who have published with MDPI during their careers. Below are links to their MDPI publications and announcements for further reading:
- Omar M. Yaghi (Chemistry)
- Awarded for his pioneering work on metal-organic frameworks (MOFs). MDPI published his article “Covalent Organic Frameworks: Organic Chemistry Beyond the Molecule” in Molecules (2017).
- MDPI Announcement: https://www.mdpi.com/news/13455
- Nobel Prize in Chemistry – The Science Behind the Prize
- Shimon Sakaguchi (Medicine)
- Recognized for discoveries in immune-system self-tolerance and regulatory T-cells. Published in Cancers (2021).
- MDPI Announcement: https://www.mdpi.com/news/13443
- Nobel Prize in Physiology or Medicine – The Science Behind the Prize
- John M. Martinis (Physics)
- Recognized for quantum tunnelling in electrical circuits. MDPI’s Journal of Nuclear Engineering (2025) includes his co-authored work.
- MDPI Announcement: https://www.mdpi.com/news/13450
- Nobel Prize in Physics – The Science Behind the Prize
These connections strengthen our mission to make research freely available and ensure that transformative ideas reach the widest possible audience.
Publishing at the leading edge of knowledge
The privilege of hosting such contributors resonates deeply with our editorial teams. It shows that top-tier scientific work has a home at MDPI, which builds our visibility in the research community. It signals that our publishing model, our editorial workflows, and our commitment to Open Access are respected at the very highest levels of science. It also gives our authors, reviewers, editors and staff the message that the work we support can be world-class and world-changing.
Publishing at the leading edge of knowledge isn’t just about individual papers – it’s about the ecosystem of support, transparency, and accessibility that makes discovery possible. Let’s continue to build a publishing platform and provide a service that attracts and enables both everyday research and the breakthroughs of tomorrow.
Inside MDPI

Strengthening Research Integrity: MDPI partners with Proofig AI
I’m pleased to share that MDPI has entered a multi-year partnership with Proofig AI, a leader in AI-driven proofing and integrity software for scientific publishing. This follows the success of our pilot program, in which Proofig AI proved highly effective in detecting duplicated, altered, and manipulated images across biomedical submissions.
Safeguarding the credibility of the research we publish
Research integrity is at the core of MDPI’s mission. The life sciences, in particular, face increasing risks of image-related issues due to advanced editing tools and generative AI. By integrating Proofig AI into our workflows, we improve our ability to detect issues early, reduce post-publication corrections, and safeguard the credibility of the research we publish.
Pilot outcomes
- Successful detection of duplicated confocal and histology images, even when altered to disguise similarities.
- Early results showed a significant drop in post-publication image manipulation flags year-on-year.
- Positive feedback from editors and staff highlighted the tool’s ease of use and reliability.

Dr. Dror Kolodkin-Gal (co-founder and CEO of Proofig AI) said:
“The MDPI team conducted a highly professional and carefully monitored pilot, achieving excellent results in detecting problematic images.
Their fast and effective integration process was impressive, and we are excited to contribute to this important collaboration.”

Sanita Meijere (IT Product and Project Manager, MDPI), shared:
“For more than a year, we’ve tested all the available image manipulation detection tools. Proofig AI’s quality and ease of use, alongside positive feedback from our internal users, made their software a clear stand-out.
We’re thrilled to be moving forward with this partnership, ensuring we do our utmost to protect MDPI’s biomedical journals. Using this advanced image proofing software reaffirms MDPI’s commitment to maintaining the highest standards in research integrity.”
Raising the bar for integrity
This partnership sets a new benchmark for quality control in biomedical publishing.

As Tim Tait-Jamieson (Head of Publication Ethics, MDPI), explains:
“The life sciences are disproportionately affected by research integrity issues, making vigilance in this field especially critical. This is driven, in part, by the increasing sophistication of image editing software and generative AI.
Whether accidental or deliberate, image manipulation can have a lasting impact on credibility. By integrating Proofig AI into our editorial workflows, we strengthen our ability to detect scientific misconduct early and reduce post-publication amendments.”
Faster and more accurate quality control
Proofig will automatically flag potentially problematic images during submission checks, giving our editors more confidence in the integrity of manuscripts and freeing up time to focus on editorial decisions. The tool will also reduce the burden of manual checks, while supporting faster and more accurate quality control. This partnership reinforces MDPI's reputation as a publisher that takes integrity seriously and continues to invest in tools to support authors, editors, and reviewers alike.
A big thank-you to all colleagues who supported the pilot and rollout. You can read more in our MDPI Blog post.
Coming Together for Science

The MDPI Romania Summit 2025
On 21–22 October, I had the pleasure of joining our colleagues in Bucharest for the MDPI Romania Summit 2025. The event was organized by our Romania Marketing team, with support from colleagues across our Romanian offices. It brought together academics, policymakers, and collaborators to discuss the country’s evolving research landscape.
Over two days, we welcomed more than 30 participants, including Editorial Board Members, Guest Editors, and policy-makers from the Romanian research and education sectors, including representatives from the Romanian Academy and the National Commission for the Accreditation of Academic Titles (CNATDCU).
The discussions and presentations reflected the strength and growth of Romania’s research community and its active engagement in Open Access publishing.
|
|
|
|
“The discussions and presentations reflected the strength and growth of Romania’s research community”
Romania’s role in Open Access
Romania loves Open Access and has emerged as one of MDPI’s most engaged national research communities. The numbers speak for themselves:
- 67% of all publications in Romania were Open Access in 2024.
- MDPI accounts for 39% of the country’s total OA publications (14,779 in 2024).
- Over the last five years (2020–2024), Romanian institutions published over 33,000 papers with MDPI.
- There are 460 active Editorial Board Members from Romania, including 8 Chief Editors.
- 29 institutions are part of our Institutional Open Access Program (IOAP), with 8 new members joining in 2025.
These numbers reflect the trust and reliable partnership we have built with the Romanian academic community.
Highlights from the Summit
The program covered a wide range of topics from MDPI’s achievements and updates to our editorial processes, peer-review quality, AI in publishing, IOAP and Open Access funding models, and publication ethics.
|
|
|
|
|
|
|
|
Agenda Highlights:
- MDPI Introduction, Performance & Achievements, and Collaboration with Romania – Stefan Tochev (CEO, MDPI).
- Trust the Process: Editorial Workflow and Quality in Publishing – Dr. Liliane Auwerter (Scientific Review Group).
- Publication Ethics at MDPI: Safeguarding the Integrity of the Published Scholarly Record – Diana Cristina Apodaritei (Research Integrity Specialist).
- Institutional Partnerships – Becky Castellon (Institutional Partnerships Manager, MDPI).
- AI in Publishing and MDPI's Actions – Sanita Meijere (AI Product Manager).
- Closing Remarks – Stefan Tochev (CEO, MDPI).
Participants shared feedback and ideas for future collaborations, including organizing author workshops, possible conference collaborations, and strengthening our engagement with national institutions such as the Ministry of Education and Research and the National Council of Romanian Rectors.
As Acad. Dr. Nicolae-Victor Zamfir, Vice President of the Romanian Academy, noted during the discussions:
“The organization of the event is very timely, because MDPI is a publishing house in full development and expansion. The opinion of researchers is important for increasing the quality of published works.”
A collaborative future
Events like this remind us how essential it is to engage locally and listen directly to the voices of our editors, authors, and institutional partners. They help us build relationships, improve our understanding of the local market, and align our shared goals in advancing Open Access and research quality.
Thank you to everyone involved, especially our Romania Marketing team, who organized the event, and to all colleagues who continue to build relationships with our academic communities around the world.

Thank you!
A special thank-you to the Romanian Marketing team and all colleagues behind the scenes who made this Summit such a success. Your efforts are greatly appreciated. We look forward to building on this momentum with future Summits in Europe and beyond.
Closing Thoughts

STM and FBF 2025: Connecting Through Science and Publishing

Stefan Tochev (CEO, MDPI), Constanze Schelhorn (Head of Indexing, MDPI) at STM Conference, Frankfurt, 14 October 2025.
On 13–14 October, I attended the STM Frankfurt Conference 2025, my fourth visit to the Frankfurt event, and it continues to be one of the most valuable gatherings in our industry.
The STM meeting brings together the publishing community and key opinion leaders to speak on current trends and challenges shaping our industry.
This year’s theme – “Science Diplomacy: What is it and How Does it Work?” – unpacked the growing intersection of science, policy, and publishing.
Discussion topics ranged from what is science diplomacy and how publishers can contribute to global collaboration to how science communication can help maintain trust during an era of disruption.
I was joined by Dr. Constanze Schelhorn, our Head of Indexing, who met with representatives from Scopus, Web of Science, Digital Science, ProQuest, and other partners. These meetings give us a chance to share feedback on our collaborations, learn about new updates being developed, and build our relationships with indexing bodies.
“The STM meeting brings together the publishing community and key opinion leaders”
STM also provides a space to connect with industry peers, as I did with colleagues from Elsevier, Frontiers, Clarivate, Sage, and STM itself, reinforcing MDPI’s engagement within the broader publishing community. It was also nice to bump into some former colleagues and see them continuing to grow in their publishing careers.
At the Frankfurt Book Fair

The MDPI booth at the 2025 Frankfurt Book Fair.
Following STM, I spent the next day at the Frankfurt Book Fair (15–19 October) – one of the largest and most influential events in the publishing world.
It’s always inspiring to see the scale and energy of this global gathering, which spans everything from books and education to digital innovation and academic publishing.
We set up an MDPI booth to host discussions with partners, vendors, and researchers.
The Fair ran into the weekend, with colleagues from several MDPI departments attending to represent the company and connect with the scholarly community.
Events like STM and FBF are a nice reminder of how dynamic and interconnected our industry is, and how important it is for MDPI to continue taking part in global conversations about science, communication, and the future of publishing.
Chief Executive Officer
MDPI AG
30 October 2025
Meet Us at the 4th International Symposium on Honey Bee Health in Asia (COLOSS Asia 2025), 14–16 November 2025, Hangzhou, China
Conference: The 4th International Symposium on Honey Bee Health in Asia (COLOSS Asia 2025)
Date: 14–16 November 2025
Location: Hangzhou, China
The International Symposium on Honey Bee Health in Asia (COLOSS Asia), initiated under the framework of COLOSS (Prevention of Honey Bee COlony LOSSes), serves as a premier platform for advancing research, fostering collaboration, and addressing critical challenges in honey bee health across Asia. Since its launch in February 2020 in Chiang Mai, Thailand, the symposium has garnered widespread participation from researchers, policymakers, and industry stakeholders.
The 4th edition, proudly hosted by Zhejiang University, will convene in Hangzhou, China, from 14 to 16 November 2025. Building on past successes, this symposium will facilitate knowledge exchange, highlight cutting-edge research, and strengthen international partnerships within the COLOSS network.
The following MDPI journals will be represented at ICIS 2025:
If you are planning to attend the above conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person and answering any questions that you may have.
For more information about the conference, please visit the following website: https://coloss.org/tdcf_tourism/coloss-asia-2025/.





















